invivodata to Demonstrate New SitePRO Tablet at Upcoming ePRO Conference

PITTSBURGH--(BUSINESS WIRE)--invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, today announced that it will demonstrate its improved SitePRO^® solution for in-clinic assessments as well as other product enhancements at its ePRO Conference 2008 to be held in Boca Raton, Fla., April 29–May 1.

invivodata’s second-generation, large-screen solution, the SitePRO Tablet, provides a single data entry source for site-based ePRO assessments, enabling clinical trial sponsors to eliminate paper-based assessments. SitePRO’s larger screen accurately captures lengthy quality-of-life and other in-clinic-based assessments, thus increasing efficiency and decreasing costs by eliminating the need for error correction and duplicate data entry that is associated with paper assessments.

Conference attendees will also learn about other key innovations that invivodata is implementing as it continues to deliver the most practical and easy-to-use ePRO solutions for clinical research:

• Feature enhancements to DiaryPRO^®, the leading patient eDiary solution
• Expanded language support for global studies
• Support for additional physiological device integrations

“We rely on input from clinical site personnel and pharmaceutical company customers to develop new ePRO offerings. This ensures that our solutions improve the patient, site and sponsor ePRO experience,” said Tom Henson, vice president of marketing at invivodata.

“Our SitePRO Tablet is a great example of combining our extensive in-clinic PRO data collection experience using large-screen devices with significant sponsor and site input to develop an intuitive solution that will further improve ease of use, data accuracy and trial efficiencies.”

For more information and to register for the ePRO Conference, visit http://www.invivodata.com/epro2008.

About invivodata inc.

invivodata combines behavioral science, information technology and clinical expertise to capture clinical trial data of the highest integrity directly from patients. invivodata’s electronic Patient Reported Outcomes (ePRO) system delivers high-quality patient self-reported data by driving patient compliance with the protocol and eliminating recall biases that plague self-report studies. The invivodata solution, which includes DiaryPRO for real-time PRO data collection and SitePRO for site-based PRO data collection, provides access to study data, giving researchers and sponsors visibility into study progress and improving trial efficiencies. invivodata’s solution has been used in more than 200 trials and is the industry-leading eDiary system in delivering primary efficacy data for FDA drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, Pa., USA; its European headquarters are in London, England; and its technology development center is in Scotts Valley, Calif., USA. For more information visit www.invivodata.com.